Primecap Management Portfolio holdings
AUM
$126B
1-Year Return
17.42%
This Quarter Return
+1.82%
1 Year Return
+17.42%
3 Year Return
+102.42%
5 Year Return
+196.08%
10 Year Return
+554.06%
AUM
$129B
AUM Growth
-$6.89B
(-5.1%)
Cap. Flow
-$4.92B
Cap. Flow
% of AUM
-3.81%
Top 10 Holdings %
Top 10 Hldgs %
33.07%
Holding
342
New
6
Increased
53
Reduced
242
Closed
13
Top Buys
| 1 |
GSK
GSK
|
$352M |
| 2 |
Amazon
AMZN
|
$239M |
| 3 |
Charles Schwab
SCHW
|
$238M |
| 4 |
Applovin
APP
|
$113M |
| 5 |
Spotify
SPOT
|
$98.3M |
Top Sells
| 1 |
Eli Lilly
LLY
|
$721M |
| 2 |
Tesla
TSLA
|
$470M |
| 3 |
Wells Fargo
WFC
|
$455M |
| 4 |
Amgen
AMGN
|
$327M |
| 5 |
Alphabet (Google) Class A
GOOGL
|
$319M |
Sector Composition
| 1 | Technology | 29.81% |
| 2 | Healthcare | 28.01% |
| 3 | Industrials | 12.89% |
| 4 | Consumer Discretionary | 10.09% |
| 5 | Financials | 8.46% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
276
Victoria's Secret
VSCO
$2.05B
| $4.84M | ﹤0.01% |
116,933
-1,654,683
| -93% | -$68.5M |
|
277
Savers
SVV
$1.98B
| $4.84M | ﹤0.01% |
471,750
+409,850
| +662% | +$4.2M |
|
278
Zentalis Pharmaceuticals
ZNTL
$128M
| $4.61M | ﹤0.01% |
1,520,630
+22,600
| +2% | +$68.5K |
|
279
Brinker International
EAT
$7.11B
| $4.6M | ﹤0.01% |
34,800
| – | – |
|
280
Repligen
RGEN
$6.78B
| $4.44M | ﹤0.01% |
30,858
-23,871
| -44% | -$3.44M |
|
281
Nurix Therapeutics
NRIX
$697M
| $4.37M | ﹤0.01% |
232,000
-58,000
| -20% | -$1.09M |
|
282
Rambus
RMBS
$8.11B
| $4.36M | ﹤0.01% |
82,500
-12,000
| -13% | -$634K |
|
|
OS
283
OneStream, Inc. Class A Common Stock
OS
$3.66B
| $4.13M | ﹤0.01% |
144,700
-121,300
| -46% | -$3.46M |
|
284
Allegiant Air
ALGT
$1.18B
| $3.87M | ﹤0.01% |
41,150
| – | – |
|
285
Rivian
RIVN
$16.6B
| $3.51M | ﹤0.01% |
263,940
-22,240
| -8% | -$296K |
|
286
Globus Medical
GMED
$8.14B
| $3.41M | ﹤0.01% |
41,225
-5,000
| -11% | -$414K |
|
|
LUCK
287
Lucky Strike Entertainment Corporation
LUCK
$1.46B
| $3.27M | ﹤0.01% |
326,900
| – | – |
|
288
Take-Two Interactive
TTWO
$44.4B
| $3.25M | ﹤0.01% |
+17,639
| New | +$3.25M |
|
289
Immunome
IMNM
$853M
| $2.98M | ﹤0.01% |
280,800
| – | – |
|
290
Ivanhoe Electric
IE
$1.18B
| $2.96M | ﹤0.01% |
391,800
-34,000
| -8% | -$257K |
|
291
Roblox
RBLX
$90B
| $2.91M | ﹤0.01% |
50,300
| – | – |
|
292
Danaher
DHR
$143B
| $2.85M | ﹤0.01% |
12,402
-19,535
| -61% | -$4.48M |
|
293
Leslie's
LESL
$63.8M
| $2.81M | ﹤0.01% |
1,260,900
+284,100
| +29% | +$634K |
|
294
Ingevity
NGVT
$2.15B
| $2.81M | ﹤0.01% |
69,000
| – | – |
|
295
nLIGHT
LASR
$1.47B
| $2.75M | ﹤0.01% |
262,129
-1,050
| -0.4% | -$11K |
|
296
Frontier Group Holdings
ULCC
$1.18B
| $2.73M | ﹤0.01% |
384,300
+117,700
| +44% | +$837K |
|
297
JELD-WEN Holding
JELD
$552M
| $2.56M | ﹤0.01% |
312,300
| – | – |
|
298
Dollar General
DG
$23.9B
| $2.45M | ﹤0.01% |
32,350
-82,000
| -72% | -$6.22M |
|
299
FibroGen
FGEN
$45.7M
| $2.44M | ﹤0.01% |
184,645
-211,804
| -53% | -$2.8M |
|
300
Cerus
CERS
$255M
| $2.38M | ﹤0.01% |
1,544,300
-6,999,700
| -82% | -$10.8M |
|